Association among VKORC1 rs9923231, CYP4F2 rs2108622, GGCX rs11676382 polymorphisms and acute ischemic stroke

Medicine (Baltimore). 2023 Aug 25;102(34):e34836. doi: 10.1097/MD.0000000000034836.

Abstract

Acute ischemic stroke is a major cause of morbidity and mortality worldwide, and genetic factors play a role in the risk of stroke. Single nucleotide polymorphisms (SNPs) in the VKORC1, CYP4F2, and GGCX genes have been linked to clinical outcomes, such as bleeding and cardiovascular diseases. This study aimed to investigate the association between specific polymorphisms in these genes and the risk of developing the first episode of acute ischemic stroke in patients without a known embolic source. This retrospective, cross-sectional, observational, analytical, case-control study included adult patients diagnosed with acute ischemic stroke. The SNPs in VKORC1 rs9923231, CYP4F2 rs2108622, GGCX rs11676382 genes were genotyped and analyzed together with the demographic and clinical factors of the 2 groups of patients. The presence of SNPs in VKORC1 or CYP4F2 genes significantly increased the risk of ischemic stroke in the context of smoking, arterial hypertension, and carotid plaque burden. The multivariate logistic model revealed that smoking (odds ratio [OR] = 3.920; P < .001), the presence of carotid plaques (OR = 2.661; P < .001) and low-density lipoprotein cholesterol values >77 mg/dL (OR = 2.574; P < .001) were independently associated with stroke. Polymorphisms in the VKORC1 and CYP4F2 genes may increase the risk of ischemic stroke in patients without a determined embolic source. Smoking, the presence of carotid plaques, and high low-density lipoprotein cholesterol levels were reconfirmed as important factors associated with ischemic stroke.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Case-Control Studies
  • Cholesterol, LDL
  • Cross-Sectional Studies
  • Cytochrome P450 Family 4 / genetics
  • Humans
  • Ischemic Stroke*
  • Polymorphism, Single Nucleotide
  • Retrospective Studies
  • Stroke* / genetics
  • Vitamin K Epoxide Reductases / genetics

Substances

  • Cholesterol, LDL
  • CYP4F2 protein, human
  • Cytochrome P450 Family 4
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases